BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32921049)

  • 1. Krisynomycins, Imipenem Potentiators against Methicillin-Resistant
    Pérez-Bonilla M; Oves-Costales D; González I; de la Cruz M; Martín J; Vicente F; Genilloud O; Reyes F
    J Nat Prod; 2020 Sep; 83(9):2597-2606. PubMed ID: 32921049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fijimycins A-C, three antibacterial etamycin-class depsipeptides from a marine-derived Streptomyces sp.
    Sun P; Maloney KN; Nam SJ; Haste NM; Raju R; Aalbersberg W; Jensen PR; Nizet V; Hensler ME; Fenical W
    Bioorg Med Chem; 2011 Nov; 19(22):6557-62. PubMed ID: 21745747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Xanthoradones, new potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2 II. Structure elucidation.
    Yamazaki H; Omura S; Tomoda H
    J Antibiot (Tokyo); 2009 Aug; 62(8):435-7. PubMed ID: 19609292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthoradones, new potentiators of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2: I. Taxonomy, fermentation, isolation and biological properties.
    Yamazaki H; Nonaka K; Masuma R; Omura S; Tomoda H
    J Antibiot (Tokyo); 2009 Aug; 62(8):431-4. PubMed ID: 19629141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naphthacemycins, novel circumventors of β-lactam resistance in MRSA, produced by Streptomyces sp. KB-3346-5. I. The taxonomy of the producing strain, and the fermentation, isolation and antibacterial activities.
    Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Suzuki M; Onodera H; Tomoda H; Matsui H; Hanaki H; Iwatsuki M; Ōmura S; Shiomi K
    J Antibiot (Tokyo); 2017 May; 70(5):562-567. PubMed ID: 28293038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New ikarugamycin derivatives with antifungal and antibacterial properties from Streptomyces zhaozhouensis.
    Lacret R; Oves-Costales D; Gómez C; Díaz C; de la Cruz M; Pérez-Victoria I; Vicente F; Genilloud O; Reyes F
    Mar Drugs; 2014 Dec; 13(1):128-40. PubMed ID: 25551780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
    Sharma M; Manhas RK
    BMC Microbiol; 2019 Feb; 19(1):44. PubMed ID: 30782119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of nosokophic acid, a predicted intermediate of moenomycins, from nosokomycin-producing Streptomyces sp. K04-0144.
    Koyama N; Tokura Y; Takahashi Y; Tomoda H
    Bioorg Med Chem Lett; 2013 Feb; 23(3):860-3. PubMed ID: 23265883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stemphones, novel potentiators of imipenem activity against methicillin-resistant staphylococcus aureus, produced by Aspergillus sp. FKI-2136.
    Koyama N; Nagahiro T; Yamaguchi Y; Masuma R; Tomoda H; Omura S
    J Antibiot (Tokyo); 2005 Nov; 58(11):695-703. PubMed ID: 16466023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enduracidin analogues with altered halogenation patterns produced by genetically engineered strains of Streptomyces fungicidicus.
    Yin X; Chen Y; Zhang L; Wang Y; Zabriskie TM
    J Nat Prod; 2010 Apr; 73(4):583-9. PubMed ID: 20353165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomics-Driven Discovery of Chlorinated Cyclic Hexapeptides Ulleungmycins A and B from a Streptomyces Species.
    Son S; Hong YS; Jang M; Heo KT; Lee B; Jang JP; Kim JW; Ryoo IJ; Kim WG; Ko SK; Kim BY; Jang JH; Ahn JS
    J Nat Prod; 2017 Nov; 80(11):3025-3031. PubMed ID: 29083895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MDN-0171, a new medermycin analogue from Streptomyces albolongus CA-186053.
    Lacret R; Oves-Costales D; Pérez-Victoria I; de la Cruz M; Díaz C; Vicente F; Genilloud O; Reyes F
    Nat Prod Res; 2019 Jan; 33(1):66-73. PubMed ID: 29411643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synergistic antibacterial activity of 1-acetyl-beta-carboline and beta-lactams against methicillin-resistant Staphylococcus aureus (MRSA).
    Shin HJ; Lee HS; Lee DS
    J Microbiol Biotechnol; 2010 Mar; 20(3):501-5. PubMed ID: 20372018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. I. Taxonomy, fermentation, isolation and structural elucidation.
    Fukumoto A; Kim YP; Matsumoto A; Takahashi Y; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):1-6. PubMed ID: 18305352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDN-0170, a New Napyradiomycin from Streptomyces sp. Strain CA-271078.
    Lacret R; Pérez-Victoria I; Oves-Costales D; de la Cruz M; Domingo E; Martín J; Díaz C; Vicente F; Genilloud O; Reyes F
    Mar Drugs; 2016 Oct; 14(10):. PubMed ID: 27763545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xanthoradone C, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Penicillium radicum FKI-3765-2.
    Yamazaki H; Omura S; Tomoda H
    J Antibiot (Tokyo); 2010 Jun; 63(6):329-30. PubMed ID: 20431614
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.
    Zhang W; Li Y; Qian G; Wang Y; Chen H; Li YZ; Liu F; Shen Y; Du L
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5581-9. PubMed ID: 21930890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two piperazic acid-containing cyclic hexapeptides from Streptomyces alboflavus 313.
    Wei S; Fan L; Wu W; Ji Z
    Amino Acids; 2012 Nov; 43(5):2191-8. PubMed ID: 22543750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NW-G01, a novel cyclic hexadepsipeptide antibiotic, produced by Streptomyces alboflavus 313: I. Taxonomy, fermentation, isolation, physicochemical properties and antibacterial activities.
    Guo Z; Shen L; Ji Z; Zhang J; Huang L; Wu W
    J Antibiot (Tokyo); 2009 Apr; 62(4):201-5. PubMed ID: 19265870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.